Saved source record
Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis.
This is a source-metadata record last found in a complete check on Sep 28, 2026. It is not a Pependium assessment of safety or effectiveness. Check the original sources for current details, corrections and full methods.
Source status: This saved record has not yet had a scheduled exact-ID status check. Check its original source links.
Study metadata
- Study type
- Original analysis
- Study category (metadata hint)
- Economic model
- Source date
- Published: 2022-12-27
- Authors
- Azuri J, Hammerman A, Aboalhasan E, Sluckis B, Arbel R.
- Journal or registry
- Diabetes, obesity & metabolism
- Registry study design
- Not reported
- Registry enrollment
- Not reported
- Funding agencies
- Not reported in source metadata
- Identifiers
- DOI: 10.1111/dom.14940 · PMID: 36507900
- First found
- Sep 28, 2026
- Last found
- Sep 28, 2026
Original sources
Browse saved studies · Search live sources